Trial · NCT04677803
BT200 in Hereditary Bleeding Disorders
NCT04677803, Phase 2, Completed, Medical University of Vienna
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. BT200 in Hereditary Bleeding Disorders. Trials, record NCT04677803. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04677803
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- BT200 in Hereditary Bleeding Disorders
- NCT number
- NCT04677803
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 26 participants, actual
- Lead sponsor
- Medical University of Vienna
- Conditions
- Von Willebrand Diseases, Hemophilia A
- Interventions
- BT200
- First posted
- 2020-12-21
- Last updated
- 2021-11-11
Source ClinicalTrials.gov
Registered outcomes20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Hemophilia A | Baseline through 4 weeks after dosing | increase in FVIII activity |
| Primary | VWD Type 1 | Baseline through 4 weeks after dosing | increase in FVIII activity |
| Primary | VWD Type 2b | Baseline through 4 weeks after dosing | increase in platelet count and/or FVIII activity |
| Secondary | Pharmacokinetic (PK) Measured concentration of BT200 (and derived PK parameters) | Baseline through 4 weeks after dosing | Measured concentration of BT200 |
| Secondary | Pharmacodynamics | Baseline through 4 weeks after dosing | PFA-100 |
| Secondary | Pharmacodynamics | Baseline through 4 weeks after dosing | Multiplate electrode platelet aggregometer (ristocetin induced) |
| Secondary | Pharmacodynamics | Baseline through 4 weeks after dosing | VWF antigen |
| Secondary | Pharmacodynamics | Baseline through 4 weeks after dosing | VWF:ristocetin co-factor assay |
| Secondary | Pharmacodynamics | Baseline through 4 weeks after dosing | VWF activity |
| Secondary | Pharmacodynamics | Baseline through 4 weeks after dosing | VWF collagen bindign assay |
1 to 10 of 20Source ClinicalTrials.gov
See all 20 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04677803
GET https://conductscience.org/api/trials/v1/NCT04677803/registered